Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2016, Article ID 1973086, 7 pages
http://dx.doi.org/10.1155/2016/1973086
Research Article

Identifying Risk Factors Associated with Inappropriate Use of Acid Suppressive Therapy at a Community Hospital

Crozer Chester Medical Center, Upland, Philadelphia, PA, USA

Received 25 May 2016; Accepted 21 September 2016

Academic Editor: Greger Lindberg

Copyright © 2016 Amandeep Singh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. R. Grube and D. B. May, “Stress ulcer prophylaxis in hospitalized patients not in intensive care units,” American Journal of Health-System Pharmacy, vol. 64, no. 13, pp. 1396–1400, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis, “ASHP commission on therapeutics and approved by the ASHP board of directors on November 14, 1998,” American Journal of Health-System Pharmacy: AJHP: Official Journal of the American Society of Health-System Pharmacists, vol. 56, no. 4, pp. 347–379, 1998. View at Google Scholar
  3. R. J. Nardino, R. J. Vender, and P. N. Herbert, “Overuse of acid-suppressive therapy in hospitalized patients,” The American Journal of Gastroenterology, vol. 95, no. 11, pp. 3118–3122, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Parente, C. Cucino, S. Gallus et al., “Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: a 1-month survey,” Alimentary Pharmacology & Therapeutics, vol. 17, no. 12, pp. 1503–1506, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Ramírez, S. H. Lei, A. M. Borobia et al., “Overuse of PPIs in patients at admission, during hospitalisation, and at discharge in a terciary Spanish hospital,” Current Clinical Pharmacology, vol. 5, no. 4, pp. 288–297, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. D. A. Zink, M. Pohlman, M. Barnes, and M. E. Cannon, “Long-term use of acid suppression started inappropriately during hospitalization,” Alimentary Pharmacology & Therapeutics, vol. 21, no. 10, pp. 1203–1209, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. K. B. Yap and K. M. Chan, “The prescribing pattern of hospital doctors,” Singapore Medical Journal, vol. 39, no. 11, pp. 496–500, 1998. View at Google Scholar · View at Scopus
  8. I. A. Issa, O. Soubra, H. Nakkash, and L. Soubra, “Variables associated with stress ulcer prophylaxis misuse: a retrospective analysis,” Digestive Diseases and Sciences, vol. 57, no. 10, pp. 2633–2641, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Afif, R. Alsulaiman, M. Martel, and A. N. Barkun, “Predictors of inappropriate utilization of intravenous proton pump inhibitors,” Alimentary Pharmacology and Therapeutics, vol. 25, no. 5, pp. 609–615, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. I. M. Carey, S. De Wilde, T. Harris et al., “What factors predict potentially inappropriate primary care prescribing in older people? Analysis of UK primary care patient record database,” Drugs & Aging, vol. 25, no. 8, pp. 693–706, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. D. G. N. Craig, R. Thimappa, V. Anand, and S. Sebastian, “Inappropriate utilization of intravenous proton pump inhibitors in hospital practice—a prospective study of the extent of the problem and predictive factors,” Quarterly Journal of Medicine, vol. 103, no. 5, pp. 327–335, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. M. S. Alsultan, A. Y. Mayet, A. A. Malhani, and M. K. Alshaikh, “Pattern of intravenous proton pump inhibitors use in ICU and Non-ICU setting: a prospective observational study,” Saudi Journal of Gastroenterology, vol. 16, no. 4, pp. 275–279, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Y. Mayet, “Improper use of antisecretory drugs in a tertiary care teaching hospital: An Observational Study,” Saudi Journal of Gastroenterology, vol. 13, no. 3, pp. 124–128, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. D. J. Cook, L. G. Witt, R. J. Cook, and G. H. Guyatt, “Stress ulcer prophylaxis in the critically III: a meta-analysis,” The American Journal of Medicine, vol. 91, no. 5, pp. 519–527, 1991. View at Publisher · View at Google Scholar · View at Scopus
  15. K. O. Hwang, S. Kolarov, L. Cheng, and R. A. Griffith, “Stress ulcer prophylaxis for non-critically ill patients on a teaching service,” Journal of Evaluation in Clinical Practice, vol. 13, no. 5, pp. 716–721, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. I. Kantorova, P. Svoboda, P. Scheer et al., “Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial,” Hepato-Gastroenterology, vol. 51, no. 57, pp. 757–761, 2004. View at Google Scholar · View at Scopus
  17. S. J. Herzig, M. D. Howell, L. H. Ngo, and E. R. Marcantonio, “Acid-suppressive medication use and the risk for hospital-acquired pneumonia,” The Journal of the American Medical Association, vol. 301, no. 20, pp. 2120–2128, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Cunningham, B. Dale, B. Undy, and N. Gaunt, “Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea,” The Journal of Hospital Infection, vol. 54, no. 3, pp. 243–245, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Dial, K. Alrasadi, C. Manoukin, A. Huang, and D. Menzies, “Risk of Clostridium difficile diaarhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies,” Canadian Medical Association Journal, vol. 171, no. 1, pp. 33–38, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. J. J. Heidelbaugh and J. M. Inadomi, “Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients,” The American Journal of Gastroenterology, vol. 101, no. 10, pp. 2200–2205, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. J. D. Liberman and C. T. Whelan, “Brief report: reducing inappropriate usage of stress ulcer prophylaxis among internal medicine residents. A practice-based educational intervention,” Journal of General Internal Medicine, vol. 21, no. 5, pp. 498–500, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. J. D. Hughes, W. Tanpurekul, N. C. Keen, and H. C. Ee, “Reducing the cost of proton pump inhibitors by adopting best practice,” Quality in Primary Care, vol. 17, no. 1, pp. 15–21, 2009. View at Google Scholar · View at Scopus
  23. R. Atkins and L. Smith, “Impact of pharmacy intervention on the use of proton-pump inhibitors in the hospital setting,” The Consultant Pharmacist, vol. 28, no. 12, pp. 786–792, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. L. M. Lucas, M. S. Gerrity, and T. Anderson, “A practice-based approach for converting from proton pump inhibitors to less costly therapy,” Effective Clinical Practice, vol. 4, no. 6, pp. 263–270, 2001. View at Google Scholar · View at Scopus